文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

是时候重新考虑在重症患者中单用维生素B1或联合维生素C给药了吗?一项临床试验的Meta分析

Is it time to reconsider the administration of thiamine alone or in combination with vitamin C in critically ill patients? A meta-analysis of clinical trial studies.
PubMed 文献 · J Intensive Care · 2022-02-17
一句话结论Meta分析显示:单用维生素B1与ICU病死率升高相关,而氢化可的松+维生素C+维生素B1(HVT)可降低病死率,维生素B1联合维生素C可降低SOFA评分。

该Meta分析纳入20项干预性研究,评估单用维生素B1、维生素B1联合维生素C、以及低剂量氢化可的松+维生素C+维生素B1(HVT)对重症患者临床结局的影响。结果显示,单用维生素B1与病死率升高相关(WMD:5.17%;95%CI:2.67, 7.67),HVT可降低病死率(WMD:-7.23%;95%CI:-10.31, -4.16;I²=0.0%),而维生素B1联合维生素C对病死率无显著影响。维生素B1联合维生素C可显著降低SOFA评分(WMD:-0.73;95%CI:-1.29, -0.17;I²=0.0%)。三种方案对无 ventilator-free days 和ICU住院时间均无显著影响,单用维生素B1和HVT对SOFA评分无显著影响。

要点

  • 单用维生素B1与ICU病死率升高相关(WMD:5.17%;95%CI:2.67, 7.67)。
  • HVT(低剂量氢化可的松+维生素C+维生素B1)可降低病死率(WMD:-7.23%;95%CI:-10.31, -4.16;I²=0.0%)。
  • 维生素B1联合维生素C对病死率无显著影响,但可显著降低SOFA评分(WMD:-0.73;95%CI:-1.29, -0.17;I²=0.0%)。
  • 单用维生素B1、维生素B1联合维生素C及HVT对无 ventilator-free days 和ICU住院时间均无显著影响。
  • 单用维生素B1和HVT对SOFA评分无显著影响。

适用人群与场景

  • 重症患者(纳入的20项干预性研究涉及的重症人群)。

研究设计与关键结果

  • 研究类型:Meta分析,纳入20项干预性研究(RCT和干预性研究),最初检索到3367篇文献。
  • 单用维生素B1与病死率升高相关(WMD:5.17%;95%CI:2.67, 7.67)。
  • 维生素B1联合维生素C对病死率无显著影响。
  • HVT可降低病死率(WMD:-7.23%;95%CI:-10.31, -4.16;I²=0.0%)。
  • 维生素B1联合维生素C及HVT对无 ventilator-free days 无显著影响;单用维生素B1对无 ventilator-free days 无显著影响(原文未单独列出数值)。
  • 单用维生素B1、维生素B1联合维生素C及HVT对ICU住院时间均无显著影响。
  • 单用维生素B1和HVT对SOFA评分无显著影响;维生素B1联合维生素C可显著降低SOFA评分(WMD:-0.73;95%CI:-1.29, -0.17;I²=0.0%)。

证据类型、等级与局限

  • 证据类型:Meta分析(纳入RCT和干预性研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与HVT不同,单用维生素B1与ICU病死率升高相关;维生素B1联合维生素C可显著降低SOFA评分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Although the effect of thiamine alone or in combination with vitamin C has been studied in multiple trials (RCT and interventional studies), their results are inconsistent. This meta-analysis aimed to assess impact of thiamine administration alone, thiamine in combination with vitamin C, and co-administration of low-dose hydrocortisone, vitamin C and thiamine (HVT) on clinical outcomes in critically ill patients.

METHODS AND MATERIALS: After electronic searches on PubMed, Scopus, Cochrane Library, and Web of Science databases, initially 3367 papers were found, and 20 interventional studies were included in our analysis. We assessed the risk-difference between treatment and control (standard treatment) groups by pooling available data on ICU length of stay, number of ventilator free days, mortality, and changes in Sequential Organ Failure Assessment (SOFA) scores.

RESULTS: The results of present studies revealed no significant effect of thiamine in combination with vitamin C, and HVT on number of free days of ventilation. Thiamine alone supplementation was associated with high mortality percentage (WMD: 5.17%; 95% CI: 2.67, 7.67). Thiamine in combination with vitamin C had no significant impact on mortality rate. In contrast, HVT could decrease mortality rate (WMD: - 7.23%; 95% CI: - 10.31, - 4.16; I-square: 0.0%). There was no significant effect of thiamine alone, co-administration of thiamine and vitamin C, and HVT on ICU length of stay. The results of the meta-analysis showed that thiamine alone and HVT supplementation had no significant effect on SOFA score. Interestingly, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score (WMD: - 0.73; 95% CI: - 1.29, - 0.17; I-square: 0.0%).

CONCLUSION: In contrast to HVT, thiamine supplementation alone was associated with increased mortality rate in ICU. However, co-supplementation of thiamine and vitamin C had a significant decreasing effect on SOFA score.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Shokri-Mashhadi N, Aliyari A, Hajhashemy Z, et al. Is it time to reconsider the administration of thiamine alone or in combination with vitamin C in critically ill patients? A meta-analysis of clinical trial studies. J Intensive Care. 2022. PMID: 35177121. doi:10.1186/s40560-022-00594-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。